The Excel Medical Ventures team builds companies that apply transformative life science technology to solve problems in healthcare and beyond. The Excel investment portfolio is balanced across healthcare IT and services, diagnostics, and medical devices PLUS life science platforms that address adjacent markets including energy, chemicals, defense and agriculture. Over two thirds of the team’s prior investments, which include some of the world’s premier healthcare and life science companies, achieved successful exits generating billions in value.
| Company | Date | Round | Size | Participants |
| Tetraphase Pharmaceuticals | 6/10 | Series C | $45M | 6 |
| Saladax Biomedical | 3/10 | Series C | $8.4M | 4 |
| MedVentive | 9/09 | Series C | $7.2M | 3 |
| Aileron Therapeutic | 6/09 | Series D | $40M | 6 |